Among them, zinc, α-lipoic acid, GLP-1 and β-hydroxybutyrat alleviate the symptoms of diabetic cardiovascular complications by inhibiting autophagy, while the rest of the drugs play a therapeutic role in treating the disease by upregulating autophagy. The gene discussed is GLP1R; the disease is complication.